TEL AVIV, Israel, Feb. 12, 2019 /PRNewswire/ — Seedo Corp., “Seedo” (OTCQB: SEDO), a high-tech company providing the world’s first fully automated and controlled indoor growing machines for the cannabis and agriculture markets, has signed a memorandum of understanding for mutual research and development with SYS Technologies Ltd., a company specializing in the development and manufacture of innovative indoor and portable clean environment technologies, to deploy next-generation containerized clean growing solutions for commercial use. The systems will be applied to technology used in hospitals and research laboratories, resulting in high-quality yield of both medical cannabis and vegetables.
SYS Technologies will provide Seedo’s commercial indoor growing machines with positive air pressure clean environment technologies, resulting in pressurized growing containers that have more filtered air then the surrounding space outside the containers. The protected containers will be bacteria-free with zero environmental influence, allowing commercial operators to cost-effectively generate high yields of lab-grade, pesticide-free product. Even in the harshest environments or with limited space, cultivators can use Seedo’s intelligent systems and cloud-enabled app for secure remote monitoring and controlling to harvest the leading-edge of precision agriculture.
“We’re honored to be working in alignment with Seedo to design the future of commercial indoor growing technologies,” said Mr. Yossi Zur, CEO of SYS Technologies. “With quality standards and environmental stressors rising in cannabis and agricultural markets, our mission to provide the cleanest and highest yield of product for commercial growers is well on track in our partnership with Seedo.”
SYS Technologies offers a variety of innovative solutions and breakthrough technology in the field of indoor clean environment systems as well as portable solutions. Its clean air environment systems allow the creation of a defined space that is free of contaminants such as particles, bacteria, microbes, and more. These systems have broad applications, both in the medical field such as operating rooms and isolation facilities, and in the high-tech industry such as cleanrooms that have a variety of purposes.
“We are looking forward to the successful development and deployment of our future containerized clean growing solutions for commercial use,” said Zohar Levy, CEO of Seedo. “By adopting cutting edge technology that is already in use by governments, non-profits, hospitals and research institutes all over the world, we will meet the highest quality standards and comply with international health regulations.”
Seedo is a market leading high-tech company providing the cannabis and agriculture industries with the world’s first fully automated and controlled indoor growing machine and Commercial Containers products. Seedo provides growers with the freedom to cut costs while generating high yields of lab-grade, pesticide-free herbs and vegetables. Seedo’s AI-powered, turnkey systems enable anyone from average consumers to large-scale producers the ability to grow without prior experience or ample space. Seedo is a publicly traded company backed by a group of international investors including Cannabics Pharmaceuticals and is headquartered in Israel. For more information, visit http://www.seedolab.com
Certain statements contained in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to statements identified by words such as “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “targets,” “projects” and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, results of clinical trials and/or other studies, the challenges inherent in new product development initiatives, the effect of any competitive products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and/or regulation, potential litigation by or against us, any governmental review of our products or practices, as well as other risks discussed from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our latest Form 10-K Report filed on January 15th, 2019. We undertake no duty to update any forward-looking statement or any information contained in this press release or in other public disclosures at any time.